The Foundation will support its grantees to cover the costs related to sharing clinical trial data.
The Bill & Melinda Gates Foundation has joined Vivli as a member. The Foundation will support grantees to use the Vivli platform as an approved repository for their clinical trial data.
“By depositing and sharing data via a stable and recognized platform, this ensures the grantee’s data will be able to be reused in a sustainable manner to further enhance scientific insights” said Rebecca Li, Vivli’s Executive Director
“We believe that the tools and discoveries capable of helping us tackle the world’s most pressing challenges – from age-old diseases like malaria to newer threats like COVID-19 – can only be realized through innovative thinking and global collaboration. Access to data is critical for both of these things. This is why we are committed to increasing the impact of the research we fund so that it is findable, accessible, interoperable, and reusable through platforms like the one developed by Vivli,” Steven Kern, Deputy Director, Quantitative Sciences, The Bill & Melinda Gates Foundation.
“We’re delighted to have the Bill & Melinda Gates Foundation join as a member of Vivli and make this valuable data available. We welcome researchers interested in these important trials to visit the Vivli platform to access these datasets and potentially uncover new scientific discoveries,” said Li. “The Vivli platform is a secure and user-friendly platform to archive and share data from clinical trials, and we look forward to welcoming more funders to support their grantees to share their clinical research in the Vivli platform.”